AU2277301A - Treating allergic and inflammatory conditions - Google Patents

Treating allergic and inflammatory conditions

Info

Publication number
AU2277301A
AU2277301A AU22773/01A AU2277301A AU2277301A AU 2277301 A AU2277301 A AU 2277301A AU 22773/01 A AU22773/01 A AU 22773/01A AU 2277301 A AU2277301 A AU 2277301A AU 2277301 A AU2277301 A AU 2277301A
Authority
AU
Australia
Prior art keywords
inflammatory conditions
treating allergic
allergic
treating
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22773/01A
Other languages
English (en)
Inventor
Melton B. Affrime
Christopher R. Banfield
Samir K. Gupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2277301A publication Critical patent/AU2277301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU22773/01A 1999-12-21 2000-12-19 Treating allergic and inflammatory conditions Abandoned AU2277301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17291199P 1999-12-21 1999-12-21
US60172911 1999-12-21
PCT/US2000/034418 WO2001045688A2 (en) 1999-12-21 2000-12-19 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients

Publications (1)

Publication Number Publication Date
AU2277301A true AU2277301A (en) 2001-07-03

Family

ID=22629711

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22773/01A Abandoned AU2277301A (en) 1999-12-21 2000-12-19 Treating allergic and inflammatory conditions

Country Status (6)

Country Link
EP (1) EP1239859A2 (es)
JP (1) JP2003518045A (es)
AU (1) AU2277301A (es)
CA (1) CA2393837A1 (es)
MX (1) MXPA02006347A (es)
WO (1) WO2001045688A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup

Also Published As

Publication number Publication date
EP1239859A2 (en) 2002-09-18
WO2001045688A2 (en) 2001-06-28
CA2393837A1 (en) 2001-06-28
MXPA02006347A (es) 2002-12-13
JP2003518045A (ja) 2003-06-03
WO2001045688A3 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU5294100A (en) Method and compositions for treating the inflammatory response
AU5560600A (en) Running and testing applications
AUPQ419099A0 (en) Novel compositions and methods
AU2609901A (en) Antimicrobial compositions and methods of use
AU2001267174A1 (en) Heat-treating methods and systems
AU5826100A (en) Benzazepinones and quinazolines
AU7989400A (en) Compounds and methods
AU4827500A (en) Adaptive and generalized status monitor
AUPQ155799A0 (en) Therapeutic methods and uses
AU1359801A (en) Methods and compositions for treating reward deficiency syndrome
HK1046367A1 (zh) 治療過敏和炎症症狀
AU2001233259A1 (en) Use of desloratadine for treating allergic and inflammatory conditions
AU2002241911A1 (en) Methods to treat autoimmune and inflammatory conditions
AU7598000A (en) Antimicrobial topical composition and methods
AU1152601A (en) Compositions and their use
AU1083501A (en) Antibiotic-metal complex and methods
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
AU2002221405A1 (en) Heat-treating methods and systems
AU2002366809A1 (en) Syn3 compositions and methods
AU5875799A (en) Mip-1alpha isoform ld78beta and uses thereof
AU2277301A (en) Treating allergic and inflammatory conditions
AU7704200A (en) Treating allergic and inflammatory conditions
AU7589700A (en) Treating allergic and inflammatory conditions
AU5020700A (en) Treating allergic diseases with immunotherapy and ige antagonists
AU2669201A (en) Taccalonolides and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase